Charles River closes $380m HemaCare cell therapy takeover
Charles River Laboratories closes $380m takeover of cell therapy specialist HemaCare to expand in fast-growing sector.
Archives for January 7, 2020
BeiGene receives nod for PD-1 treatment, Boehringer begins manufacture
BeiGene’s immunotherapy becomes its first treatment to receive approval in China and Boehringer announces that it has begun manufacture of the product.
Kamada signs manufacturing deal to fill capacity vacated by Takeda
Kamada signs contract manufacturing deal ahead of anticipated loss of Takeda business.